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What is the Best Treatment for Primary Infected
Aortic Aneurysms?C.P. Gibbons*Morriston Hospital, Swansea, United KingdomPrimary infected aortic aneurysms are thankfully rare as
the surgery can be technically challenging and mortality is
about 20%. There is little information on the conservative
treatment of arterial infections with antibiotics alone but,
by the time of diagnosis, most patients have either
ruptured or developed a false aneurysm so that additional
debridement and aortic replacement is essential. In stable
patients, the diagnosis can be made from the clinical
picture and CT scan, allowing planned surgery whereas,
after rupture, the diagnosis may only become evident at
operation, which can limit therapeutic options.
The major controversy regarding treatment is how to
revascularise the lower limbs without risking secondary
graft infection. Lai and colleagues describe their experi-
ence using preferential in situ revascularisation with
a prosthetic graft. In 18 of their 34 patients, Salmonella
was the cause and in most, the aneurysm was infrarenal.
The subsequent mortality was 18% but of those without
gastrointestinal involvement, 25/26 patients survived.
Their success was probably due to thorough debridement,
omental flaps and broad-spectrum antibiotic cover. All four
patients with gastrointestinal leakage around a vascular
anastomosis died. Of two cases in which extra-anatomical
grafts were used, one died but in both aortic ligation had
been required to control haemorrhage. Consequently, this
paper is not necessarily evidence against extra-anatomical
bypass, although it does confirm that good results can be
obtained by in situ revascularisation. There were two
successful endovascular repairs but in both the infectionDOI of original article: 10.1016/j.ejvs.2011.07.005.
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doi:10.1016/j.ejvs.2011.08.002had previously been controlled by antibiotics. It therefore
remains to be seen whether endovascular grafting is wise in
the presence of active infection, despite some previous
favourable reports.
During follow-up two patients developed graft infection
and more may appear over time. Lai et al. did not use long-
term antibiotics, rifampicin-bonded or silver coated grafts
but, whilst the last two have in vitro antibacterial activity,
there is little hard evidence of clinical benefit. Cry-
opreserved allografts have increased bacterial resistance
but are expensive and are not immediately available.
Moreover, late aneurysm formation and graft rupture
occurs in a small proportion of patients.1 Nevertheless,
good results have been reported.2,3
Autogenous grafts should have the greatest resistance to
infection. Spiral long saphenous grafts have been success-
fully used for infected aortic aneurysms.4,5 Femoro-
popliteal vein grafts have been employed extensively for
aortic graft infection, are easier to prepare, are durable
and have been used for infected aneurysms.6e9 Femoro-
popliteal vein harvesting adds an hour to the operation if
only one experienced surgeon is available and so may not
be viable for ruptured aneurysms where active bleeding
necessitates initial aortic cross-clamping. Nevertheless, in
stable patients a preoperative duplex scan will show the
suitability of one or other vein so that urgent surgery can be
planned and in ruptured aneurysms it is still an option if two
operative teams can work simultaneously.
Whilst the replacement of infected aortic grafts with
femoro-popliteal vein has become accepted practice, it is
surprising that prosthetic grafts are still preferred for
primary aortic infection. Perhaps in future vascular infec-
tions, revascularisation with autogenous vein should be
considered more frequently.d by Elsevier Ltd. All rights reserved.
626 C.P. GibbonsConflict of Interest
None declared.References
1 Verhelst R, Lacroix V, Vraux H, Lavigne JP, Vandamme H,
Limet R, et al. Use of cryopreserved homografts for management
of infected prosthetic grafts: a multicentre study. Ann Vasc Surg
2000;14:602e7.
2 Bisdas T, Bredt M, Pichlmaier M, Aper T, Wilhelmi M, Bisdas S,
et al. Eight-year experience with cryopreserved arterial homo-
grafts for the in situ reconstruction of abdominal aortic infec-
tions. J Vasc Surg 2010;52:323e30.
3 Zhou W, Lin PH, Bush RL, Terramani TT, Matsuura JH, Cox M,
et al. In situ reconstruction with cryopreserved arterial allografts
for management of mycotic aneurysms or aortic prosthetic graft
infections: a multi-institutional experience. Tex Heart Inst J
2006;33:14e8.4 Heikens JT, Coveliers HM, Burger DH, van Berge Henegouwen DP,
Vriens PW. Saphenous vein spiral graft: successful emergency
repair of a mycotic aneurysm with aortoduodenal fistula. Eur J
Vasc Endovasc Surg 2006;32:408e10.
5 van Zitteren M, van der Steenhoven TJ, Burger DH, van Berge
Henegouwen DP, Heyligers JM, Vriens PW. Spiral vein recon-
struction of the infected abdominal aorta using the greater
saphenous vein: preliminary results of the Tilburg experience.
Eur J Vasc Endovasc Surg 2011;41:637e46.
6 Ehsan O, Gibbons CP. A 10-year experience of using femoro-
popliteal vein for re-vascularisation in graft and arterial infec-
tions. Eur J Vasc Endovasc Surg 2009;38:172e9.
7 Franke S, Voit R. The superficial femoral vein as an arterial substitute
in infections of the aortoiliac region.AnnVasc Surg 1997;11:406e12.
8 Brown PM, Kim VB, Lalikos JF, Deaton DH, Bogey WM, Powell CS.
Autologous superficial femoral vein for aortic reconstruction in
infected fields. Ann Vasc Surg 1999;13:32e6.
9 Rosen SF, Ledesma DF, Lopez JA, Jackson MR. Repair of a saccular
aortic aneurysm with superficial femoral-popliteal vein in the
presence of a pancreatic abscess. J Vasc Surg 2000;32:1215e8.
